Characterisation and protein expression profiling of annexins in colorectal cancer

R Duncan, B Carpenter, L C Main, C Telfer, G I Murray

Research output: Contribution to journalArticle

151 Citations (Scopus)

Abstract

The annexins are family of calcium-regulated phospholipid-binding proteins with diverse roles in cell biology. Individual annexins have been implicated in tumour development and progression, and in this investigation a range of annexins have been studied in colorectal cancer. Annexins A1, A2, A4 and A11 were identified by comparative proteomic analysis to be overexpressed in colorectal cancer. Annexins A1, A2, A4 and A11 were further studied by immunohistochemistry with a colorectal cancer tissue microarray containing primary and metastatic colorectal cancer and also normal colon. There was significant increase in expression in annexins A1 (P = 0.01), A2 (P<0.001), A4 (P<0.001) and A11 (P<0.001) in primary tumours compared with normal colon. There was increasing expression of annexins A2 (P = 0.001), A4 (P = 0.03) and A11 (P = 0.006) with increasing tumour stage. An annexin expression profile was identified by k-means cluster analysis, and the annexin profile was associated with tumour stage (P 0.01) and also patient survival. Patients in annexin cluster group 1 (low annexin expression) had a better survival (log rank = 5.33, P = 0.02) than patients in cluster group 2 (high annexins A4 and A11 expression). In conclusion, this study has shown that individual annexins are present in colorectal cancer, specific annexins are overexpressed in colorectal cancer and the annexin expression profile is associated with survival.

Original languageEnglish
Pages (from-to)426-433
Number of pages8
JournalBritish Journal of Cancer
Volume98
Issue number2
Early online date11 Dec 2007
DOIs
Publication statusPublished - 24 Jan 2008

Keywords

  • annexin
  • immunohistochemistry
  • proteomics
  • prognosis
  • tissue microarray
  • renal-cell carcinoma
  • breast-cancer
  • prostate-cancer
  • Fuhrman grade
  • I expression
  • progression
  • A1
  • esophageal
  • membrane
  • adenocarcinomas

Cite this

Characterisation and protein expression profiling of annexins in colorectal cancer. / Duncan, R; Carpenter, B; Main, L C; Telfer, C; Murray, G I.

In: British Journal of Cancer, Vol. 98, No. 2, 24.01.2008, p. 426-433.

Research output: Contribution to journalArticle

Duncan, R ; Carpenter, B ; Main, L C ; Telfer, C ; Murray, G I. / Characterisation and protein expression profiling of annexins in colorectal cancer. In: British Journal of Cancer. 2008 ; Vol. 98, No. 2. pp. 426-433.
@article{b33ed36753de430194ec8d0dd05d99a1,
title = "Characterisation and protein expression profiling of annexins in colorectal cancer",
abstract = "The annexins are family of calcium-regulated phospholipid-binding proteins with diverse roles in cell biology. Individual annexins have been implicated in tumour development and progression, and in this investigation a range of annexins have been studied in colorectal cancer. Annexins A1, A2, A4 and A11 were identified by comparative proteomic analysis to be overexpressed in colorectal cancer. Annexins A1, A2, A4 and A11 were further studied by immunohistochemistry with a colorectal cancer tissue microarray containing primary and metastatic colorectal cancer and also normal colon. There was significant increase in expression in annexins A1 (P = 0.01), A2 (P<0.001), A4 (P<0.001) and A11 (P<0.001) in primary tumours compared with normal colon. There was increasing expression of annexins A2 (P = 0.001), A4 (P = 0.03) and A11 (P = 0.006) with increasing tumour stage. An annexin expression profile was identified by k-means cluster analysis, and the annexin profile was associated with tumour stage (P 0.01) and also patient survival. Patients in annexin cluster group 1 (low annexin expression) had a better survival (log rank = 5.33, P = 0.02) than patients in cluster group 2 (high annexins A4 and A11 expression). In conclusion, this study has shown that individual annexins are present in colorectal cancer, specific annexins are overexpressed in colorectal cancer and the annexin expression profile is associated with survival.",
keywords = "annexin, immunohistochemistry, proteomics, prognosis, tissue microarray, renal-cell carcinoma, breast-cancer, prostate-cancer, Fuhrman grade, I expression, progression, A1, esophageal , membrane, adenocarcinomas",
author = "R Duncan and B Carpenter and Main, {L C} and C Telfer and Murray, {G I}",
year = "2008",
month = "1",
day = "24",
doi = "10.1038/sj.bjc.6604128",
language = "English",
volume = "98",
pages = "426--433",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Characterisation and protein expression profiling of annexins in colorectal cancer

AU - Duncan, R

AU - Carpenter, B

AU - Main, L C

AU - Telfer, C

AU - Murray, G I

PY - 2008/1/24

Y1 - 2008/1/24

N2 - The annexins are family of calcium-regulated phospholipid-binding proteins with diverse roles in cell biology. Individual annexins have been implicated in tumour development and progression, and in this investigation a range of annexins have been studied in colorectal cancer. Annexins A1, A2, A4 and A11 were identified by comparative proteomic analysis to be overexpressed in colorectal cancer. Annexins A1, A2, A4 and A11 were further studied by immunohistochemistry with a colorectal cancer tissue microarray containing primary and metastatic colorectal cancer and also normal colon. There was significant increase in expression in annexins A1 (P = 0.01), A2 (P<0.001), A4 (P<0.001) and A11 (P<0.001) in primary tumours compared with normal colon. There was increasing expression of annexins A2 (P = 0.001), A4 (P = 0.03) and A11 (P = 0.006) with increasing tumour stage. An annexin expression profile was identified by k-means cluster analysis, and the annexin profile was associated with tumour stage (P 0.01) and also patient survival. Patients in annexin cluster group 1 (low annexin expression) had a better survival (log rank = 5.33, P = 0.02) than patients in cluster group 2 (high annexins A4 and A11 expression). In conclusion, this study has shown that individual annexins are present in colorectal cancer, specific annexins are overexpressed in colorectal cancer and the annexin expression profile is associated with survival.

AB - The annexins are family of calcium-regulated phospholipid-binding proteins with diverse roles in cell biology. Individual annexins have been implicated in tumour development and progression, and in this investigation a range of annexins have been studied in colorectal cancer. Annexins A1, A2, A4 and A11 were identified by comparative proteomic analysis to be overexpressed in colorectal cancer. Annexins A1, A2, A4 and A11 were further studied by immunohistochemistry with a colorectal cancer tissue microarray containing primary and metastatic colorectal cancer and also normal colon. There was significant increase in expression in annexins A1 (P = 0.01), A2 (P<0.001), A4 (P<0.001) and A11 (P<0.001) in primary tumours compared with normal colon. There was increasing expression of annexins A2 (P = 0.001), A4 (P = 0.03) and A11 (P = 0.006) with increasing tumour stage. An annexin expression profile was identified by k-means cluster analysis, and the annexin profile was associated with tumour stage (P 0.01) and also patient survival. Patients in annexin cluster group 1 (low annexin expression) had a better survival (log rank = 5.33, P = 0.02) than patients in cluster group 2 (high annexins A4 and A11 expression). In conclusion, this study has shown that individual annexins are present in colorectal cancer, specific annexins are overexpressed in colorectal cancer and the annexin expression profile is associated with survival.

KW - annexin

KW - immunohistochemistry

KW - proteomics

KW - prognosis

KW - tissue microarray

KW - renal-cell carcinoma

KW - breast-cancer

KW - prostate-cancer

KW - Fuhrman grade

KW - I expression

KW - progression

KW - A1

KW - esophageal

KW - membrane

KW - adenocarcinomas

U2 - 10.1038/sj.bjc.6604128

DO - 10.1038/sj.bjc.6604128

M3 - Article

VL - 98

SP - 426

EP - 433

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -